Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
4.270
-0.310 (-6.77%)
At close: Sep 1, 2026, 4:00 PM EDT
5.95
+1.68 (39.34%)
After-hours: Sep 1, 2026, 7:59 PM EDT

UPC Revenue

Universe Pharmaceuticals INC had revenue of $9.04M in the half year ending March 31, 2026, a decrease of -29.87%. This brings the company's revenue in the last twelve months to $17.74M, down -8.04% year-over-year. In the fiscal year ending September 30, 2025, Universe Pharmaceuticals INC had annual revenue of $17.86M, down -22.44%.

Revenue (ttm)
$17.74M
Revenue Growth
-8.04%
P/S Ratio
0.16
Revenue / Employee
$82,139
Employees
216
Market Cap
2.78M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202517.86M-5.17M-22.44%
Sep 30, 202423.02M-9.28M-28.74%
Sep 30, 202332.31M-7.83M-19.52%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 201933.23M4.72M16.54%
Sep 30, 201828.51M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Sunshine Biopharma35.35M
IM Cannabis32.25M
cbdMD20.93M
InMed Pharmaceuticals4.94M
BioXcel Therapeutics742.00K
Gelteq314.70K
RedHill Biopharma286.00K
Akanda258.08K
Revenue Rankings